Navigation Links
Studies Report Use of USGI Medical's Incisionless Operating Platform(TM) (IOP) in Numerous Incisionless Surgical Procedures
Date:5/4/2009

Clinical Data Presented at Society of American Gastroenterological and Endoscopic Surgeons (SAGES) Annual Meeting

SAN CLEMENTE, Calif., May 4 /PRNewswire/ -- USGI Medical, Inc. (USGI), announced that its Incisionless Operating Platform(TM) (IOP) was featured in three podium sessions at the 2009 Society of American Gastroenterological and Endoscopic Surgeons (SAGES) Scientific Session & Postgraduate Course, held in Phoenix, Arizona.

Dr. Frank Borao and separately Dr. Garth Jacobsen presented on the IOP being used for an incisionless procedure designed to reduce the size of the stomach pouch and opening to the small intestine in patients who developed pouch or stoma dilatation post-Roux en Y gastric bypass (RYGB).

"After reviewing the 12-month images, I believe we demonstrated a durable incisionless revision procedure," said Frank Borao, M.D., FACS, Chief of Minimally Invasive Surgery and Medical Director for the Bariatric Surgery Program of Monmouth Medical Center. Borao's series included 21 patients followed for up to a year.

Dr. Borao reported on his 12-month post-op endoscopies confirming the durability of the procedure: the tissue anchors remained in their original locations, most of the intra-operative stoma and pouch reduction was preserved and durable tissue folds were present. The Monmouth team will continue to follow these patients for up to two years.

"Current procedures to restore the anatomy to the original post-surgery proportions are invasive, and are rarely used due to their complexity and high rate of complications leaving patients without good treatment options," Dr. Borao said. "Given the results of this series, this incisionless procedure has great potential as a safe and durable method for reducing stoma and pouch dilatation post-RYGB, filling a significant unmet medical need in this patient population."

In a third presentation, Santiago Horgan, M.D., Director of Minimally Invasive Surgery at UC San Diego Medical Center and Director of the UC San Diego Center for the Future of Surgery presented data demonstrating the IOP's utility across a number of incisionless procedures and approaches.

"A multifunctional, flexible surgery platform allows the surgeon to choose the preferred surgical approach based on the individual patient's case, which should generate better patient outcomes," Dr. Horgan said. "The vast majority of patients in this study left the hospital within a day and reported minimal pain following the procedures."

Surgical teams at UC San Diego, Legacy Health System in Portland, Oregon and Hospital Bocalandro in Buenos Aires, Argentina used the IOP to perform multiple common surgical procedures using four separate incisionless surgical approaches.

The surgeons used the IOP to perform nine cholecystectomies (gall bladder surgeries), two appendectomies; and 18 endolumenal gastric pouch and stoma reductions in post-Roux-En-Y gastric bypass (RYGB) patients. The cholecystectomy and appendectomy procedures included use of assisting laparoscopic ports with half of these procedures requiring only one. No significant complications were reported in any of the cases.

About the USGI Incisionless Operating Platform(TM) (IOP)

Combining the incisionless nature of endoscopy with the therapeutic benefit of laparoscopy, the IOP offers a stable operating platform, a level view of the operating field and access for multiple, robust, flexible surgical tools - important requirements for Incisionless Surgery. In addition, the IOP can deliver USGI's expandable tissue anchors. These anchors were designed to address the challenges of endolumenal wound closure. The expandable tissue anchors spread forces to allow improved tissue healing and surgical feel while tensioning the sutures.

About USGI Medical, Inc.

Based in San Clemente, Calif., USGI Medical, Inc. develops tools that enable Incisionless Surgery. Incisionless Surgery, which encompasses Natural Orifice Translumenal Endoscopic Surgery (NOTES), endolumenal and single-port techniques, is rapidly becoming an option demanded by patients and healthcare providers for its potential to minimize pain, shorten hospital stays, lower treatment costs and eliminate visible external scars. USGI estimates its initial target surgical markets to be around $7 billion in the U.S. Visit us at www.usgimedical.com.

    Media Contact:
    Hollister Hovey
    Lazar Partners Ltd.
    646-871-8482
    hhovey@lazarpartners.com


'/>"/>
SOURCE USCI Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Physicians Conduct Research Studies in Minutes, Not Months, at Montefiore Medical Center
2. Kessler Foundation Research Center Presented Two Studies on Post-stroke Spatial Neglect at American Academy of Neurology
3. Studies uncover high and often overlooked costs associated with epilepsy
4. Are we cherry picking participants for studies of antidepressants?
5. Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
6. Pharos Innovations and Clients to Showcase Three Client Case Studies at Upcoming ATA Conference
7. Gene Studies Reveal Cancers Secrets
8. NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR
9. Mersanas Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
10. PRA SPEAKING EVENT: Phase I Studies with Hepatitis C Compounds in Healthy Volunteers and Patients: Views from Inside
11. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-101, Potent Small Molecule for Treatment of Alzheimers Disease.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 2017 , ... After raising nearly $30,000 on Kickstarter , about three-times ... at a discounted crowdfunding price on Indiegogo . , “Along with creating an ... to bring a fidget toy to the market that was made of superior quality ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: a poignant ... of published author Laura Weigel Douglas, an avid reader who lives in the Pacific ... sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Water damage ... Lee, New Jersey School District had left education officials with a number of critical ... replacement of the flooring had to be accomplished with little or no disruption to ...
(Date:5/24/2017)... ... 24, 2017 , ... NucleusHealth ™, advancing clinical practice ... Food and Drug Administration (FDA) 510(k) clearance for its Nucleus.io ... for medical image management. At the core is patented streaming technology that provides ...
(Date:5/24/2017)... ... May 24, 2017 , ... Myers Jackson is well ... the ability to sell luxury homes anywhere on the planet. The luxury home market ... from Hattiesburg to Houston city-scapes. A quick search of “11 Spyglass Hill Auction will ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 9, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... today announced it has earned a spot on ... The Company was ranked among 500 U.S. employers as ... Healthcare Equipment and Services. The annual ... anonymous, independent survey of over 30,000 employees across 25 ...
(Date:5/9/2017)... 2017  Semler Scientific, Inc. (OTCQB: SMLR), an ... improve the clinical effectiveness and efficiency of healthcare ... quarter ended March 31, 2017. ... to identify when preventive care options are appropriate, ... heart attacks or strokes occur," said Doug ...
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
Breaking Medicine Technology: